Bonqat
Active substance
ATC code
Species
Cats
Indications
Alleviation of acute anxiety and fear associated with transportation and veterinary visits.
Dose to be administered and administration route
Oral use.
The veterinary medicinal product is administered orally as a single dose of 5 mg/kg bodyweight (0.1 ml/kg bw) approximately 1.5 hours before the start of the transportation/planned veterinary visit.
The veterinary medicinal product can be administered either directly into the mouth or mixed with a small amount of food. Large amounts of food may delay the onset of effect.
Use the oral syringe provided in the package for administration of the veterinary medicinal product.
Adverse reactions
Signs of sedation (characterised by lethargy, proprioception abnormality and ataxia) and emesis have been observed commonly in clinical studies. Muscle tremor, mydriasis, anorexia, weight loss and leucopenia have been reported uncommonly in clinical studies. Salivation has been reported rarely in clinical studies. Typically, clinical signs are mild and transient.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1 000 animals treated)
- rare (more than 1 but less than 10 animals in 10 000 animals treated)
- very rare (less than 1 animal in 10 000 animals treated, including isolated reports).
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. |
